An Act to amend and reenact §§ 59.1-200, 59.1-571, 59.1-573, and 59.1-574 of the Code of Virginia and to amend the Code of Virginia by adding in Chapter 52 of Title 59.1 an article numbered 2, consisting of sections numbered 59.1-574.1 through 59.1-574.4, relating to manufacture or sale of cosmetic products containing certain ingredients prohibited.
HB122 amends Virginia’s consumer protection and cosmetics laws to prohibit the manufacture or sale of cosmetic products containing certain ingredients identified in the bill’s new article in Title 59.1. It also updates the Virginia Consumer Protection Act’s prohibited practices section to align with the new cosmetics restrictions and related disclosure requirements, including incorporating a federal disclosure rule reference under 16 C.F.R. Part 433.
In practical terms, the bill expands the list of unlawful practices tied to consumer transactions and creates a new statutory framework in Chapter 52 of Title 59.1 governing prohibited ingredients in cosmetic products. The measure appears aimed at preventing deceptive or unsafe cosmetic sales and giving the Commonwealth additional enforcement tools against suppliers that market or sell noncompliant products.
The bill amends §§ 59.1-200, 59.1-571, 59.1-573, and 59.1-574 of the Code of Virginia and adds new §§ 59.1-574.1 through 59.1-574.4. Its effect is to broaden the Virginia Consumer Protection Act’s prohibited practices and to establish a new article regulating cosmetic products with certain prohibited ingredients, affecting manufacturers, distributors, retailers, and other suppliers involved in cosmetic sales. It also ties Virginia law to federal disclosure requirements, which may increase compliance obligations for businesses selling consumer goods in the Commonwealth.
No committee transcripts or recorded votes were provided, so there is no direct evidence of debate, opposition, or support from the legislative record included here. Based on the enacted chapter text, the bill appears to have moved through the process successfully and was approved as Chapter 910 on April 13, 2026, suggesting at least sufficient legislative support for passage.
Because no hearing transcripts or vote breakdowns are available, specific points of contention cannot be identified from the provided record. Potential areas of concern, based on the bill’s subject matter, would likely include which cosmetic ingredients are prohibited, the scope of compliance burdens on manufacturers and sellers, and how closely state requirements track federal consumer disclosure rules. Any disagreement would most likely have centered on consumer safety versus regulatory burden, but that is not documented in the materials provided.